---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-272286"
form_type: "8-K"
ticker: "FDMT"
cik: "0001650648"
company_name: "4D Molecular Therapeutics, Inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:05:15.360687+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 4D Molecular Therapeutics raises ~$93.3M net in public offering of common stock and pre-funded warrants

## Summary
- Sold 8,385,809 shares at $10.51/share and 1,128,949 pre-funded warrants at $10.5099 each.
- Net proceeds approximately $93.3M after underwriting discounts and estimated expenses.
- Offering closed on November 7, 2025; insiders subject to lock-up until January 6, 2026.

## SEC filing metadata
- accession: 0001193125-25-272286
- form_type: 8-K
- ticker: FDMT
- cik: 0001650648
- company_name: 4D Molecular Therapeutics, Inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/0001193125-25-272286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/d89818d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-272286
- JSON: https://secwatch.observer/filing/0001193125-25-272286.json
- Plain text: https://secwatch.observer/filing/0001193125-25-272286.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.